Eli Lilly Gets ITC To Launch Probe Into Diabetes Drug Imports
The U.S. International Trade Commission has agreed to look into allegations that imports of a Type 2 diabetes drug are infringing a trademark registration Eli Lilly owns....To view the full article, register now.
Already a subscriber? Click here to view full article